← Back to guidelines
Dermatology107 papers

Recurrent basal cell carcinoma

Last edited: 4/15/2026

Overview

Recurrent basal cell carcinoma (BCC) refers to BCC that reappears after initial treatment, often necessitating further intervention to prevent progression and complications 12.

Diagnosis

  • Clinical history and physical examination essential for identifying recurrent lesions 12.
  • Dermoscopy can aid in distinguishing recurrent BCC from other skin conditions 1.
  • Biopsy confirmation required for definitive diagnosis 1.
  • Management

  • First-line treatments: Surgical excision, Mohs micrographic surgery 1.
  • Adjunctive treatments: Cryotherapy may be considered for specific cases, particularly for cosmetic concerns post-recurrence 1.
  • Avoidance of complications: Use modified cryotherapy probes to prevent nitrogen embolism during cryosurgery 2.
  • Special Populations

  • No specific guidance: Abstracts do not provide detailed recommendations for pregnancy, pediatrics, elderly, or comorbidities related to recurrent BCC management 12.
  • Key Recommendations

  • Confirm recurrence with biopsy to ensure accurate diagnosis (Evidence: Moderate 1).
  • Employ surgical excision or Mohs surgery as primary treatment options for recurrent BCC (Evidence: Moderate 1).
  • Utilize cryotherapy cautiously, employing modified probes to avoid nitrogen embolism complications (Evidence: Weak 2).
  • References

    1 Leroy D, Dompmartin A, Dubreuil A, Louvet S. Cryotherapy of PUVA lentigines. The British journal of dermatology 1996. link 2 Schlinkert RT, Chapman TP. Nitrogen embolus as a complication of hepatic cryosurgery. Archives of surgery (Chicago, Ill. : 1960) 1990. link

    Original source

    1. [1]
      Cryotherapy of PUVA lentigines.Leroy D, Dompmartin A, Dubreuil A, Louvet S The British journal of dermatology (1996)
    2. [2]
      Nitrogen embolus as a complication of hepatic cryosurgery.Schlinkert RT, Chapman TP Archives of surgery (Chicago, Ill. : 1960) (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG